Xianyong Ma
Yale Medical School, USA
Biography
Xianyong Ma received his Ph.D. degree with honors in 1997 from Central South University in P. R. China, and finished his postdoctoral studies in 1999 from Yale University. Now as a research scientist he is working on the mechanism of human endometrial carcinogenesis at molecular level in Yale Medical School. He has published more than 40 papers in reputed journals, two book chapters regarding microarray chips and molecular carcinogenesis, and has been serving as an editorial board member of two reputed journals. Dr. Ma is founding member of Epigenomax Company for development of new treatment strategy of cancers and cardiologic diseases.